Literature DB >> 26245042

Role of Alpha Blockers in Hypertension with Benign Prostatic Hyperplasia.

R P Mathur, Sumanlata Nayak, R Sivaramakrishnan, Vikas Jain.   

Abstract

Hypertension and benign prostatic hyperplasia (BPH) are common disorders of aging men. As the world population is aging these two diseases are becoming a significant public health problem worldwide. Approximately 30% of men treated for BPH have coexisting hypertension. The α-Adrenergic Blockers: Prazosin, Terazosin and Doxazosin are established agents in the therapy of hypertension, and are also effective drugs in the treatment of BPH. It is reasonable to use α-Adrenergic Blockers as the treatment of choice for men with hypertension and BPH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26245042

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  2 in total

Review 1.  Treatment of Hypertension in Chronic Kidney Disease.

Authors:  Rigas G Kalaitzidis; Moses S Elisaf
Journal:  Curr Hypertens Rep       Date:  2018-06-11       Impact factor: 5.369

2.  Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients.

Authors:  Xian-Tao Zeng; Hong Weng; Jing Xiong; Qiao Huang; Lin-Lu Ma; Ying-Hui Jin; Xing-Huan Wang
Journal:  Front Physiol       Date:  2018-09-24       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.